Higher Inpatient Spending Tied to Better Outcomes

Share this content:
Higher Inpatient Spending Tied to Better Outcomes
Higher Inpatient Spending Tied to Better Outcomes

FRIDAY, July 14, 2017 (HealthDay News) -- Investing more in inpatient care relative to longer-term nursing facilities may help reduce mortality rates, according to a study published in the July issue of the Journal of Health Economics.

Joseph J. Doyle Jr., Ph.D., from the Massachusetts Institute of Technology in Cambridge, and colleagues compared U.S. health care system waste across similar patients treated at different hospitals using data from the random assignment of patients to ambulance companies. The team analyzed Medicare claims data of hospital admissions from 2002 to 2011. The final study sample yielded 1,575,273 patients who were at least 66 years old.

The researchers found that survival outcomes were modestly better with assignment to hospitals whose patients receive large amounts of care over the three months following a health emergency compared with hospitals whose patients receive less. There was a correlation for outcomes with different forms of spending. The likelihood of surviving to one year was increased for patients assigned to hospitals with high levels in inpatient spending; lower survival was seen with high levels of outpatient spending. A strong predictor of mortality was downstream spending at skilled nursing facilities (SNFs).

"Our results highlight SNF admissions as a quality measure to complement the commonly used measure of hospital readmissions and suggest that in the search for waste in the U.S. health care, post-acute SNF care is a prime candidate," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Cost-Effectiveness of PCSK9 Inhibitors Called Into Question

Cost-Effectiveness of PCSK9 Inhibitors Called Into Question

Researchers say price would have to be between $4,000 and $5,000 per year to be cost-effective

Vitamin B6, B12 Supplements May Up Risk of Lung Cancer in Men

Vitamin B6, B12 Supplements May Up Risk of ...

Increased odds only seemed to affect men or male smokers

Tablet Use Encourages Patients to Explore Diabetes Risk

Tablet Use Encourages Patients to Explore Diabetes Risk

Replacing magazines with tablets can help patients learn about diabetes risk, take preventive action

is free, fast, and customized just for you!

Already a member?

Sign In Now »